corporate communications 2012 oncology specialty survey november 2012

14
Corporate Communications 2012 Oncology Specialty Survey November 2012

Upload: jean-eileen-caldwell

Post on 30-Dec-2015

216 views

Category:

Documents


0 download

TRANSCRIPT

Corporate Communications

2012 Oncology Specialty

Survey

November 2012

2Copyright © 2012 Epocrates, Inc. All rights reserved. To learn more about Epocrates, please visit www.epocrates.com 2

Pra

ctic

e S

ize

Survey Overview

Primary mobile device platform

68%iPhone or

iPod touch

18%Android

5%Com-puter/ laptop

5%Tablet device

3%BlackBerry

1%Other

8%Solo

33%Hospital

16%Small

(3-5 physicians)

4%Partnership

15%

Large (More than 10 physicians)

20%

Mid-size (5-10 physicians)

• Survey included 321 Oncologists who use Epocrates

• Survey was conducted in October 2012

• Oncologists randomly selected to participate

n=321

3

>1 in 3 Oncologists use a Tablet in Practice

>

=

>

Other devices primary; tablet supplemental

Tablet only device used

Rarely uses tablet

Tablet primary; other device supplemental

Tablet & other devices used equally

45%

27%

15%

11%

2% 37%Plan to purchase iPad mini

80%Apple iPad

15%Android OS

Tablet utilization in practice2012 Tablet utilization by physicians

2% Other

3% Windows 7 OS

Copyright © 2012 Epocrates, Inc. All rights reserved. To learn more about Epocrates, please visit www.epocrates.com

n=105

n=122

n=321

4

Oncologists Access Epocrates Over 2 Million Times Annually with a Patient*

70%

60%Use Epocrates

Outside of the office daily

Use Epocrates During office hours

3+ times daily

Use Epocrates With a patient

daily

Copyright © 2012 Epocrates, Inc. All rights reserved. To learn more about Epocrates, please visit www.epocrates.com

n=321

Number of times physicians access Epocrates

Over

1 in 2

*Statement based on self-reported usage and extrapolated across the Epocrates member base

5

Nearly 40% of Oncologists Avoid 2+ ADEs Weekly with Epocrates

10%> 3

ADEs/ week

7%3 ADEs/ week

22%2 ADEs/ week

18%1 ADE/ week

43%< 3

ADEs/ month

Over

450,000ADEs are potentially

avoided annually with Epocrates*

Copyright © 2012 Epocrates, Inc. All rights reserved. To learn more about Epocrates, please visit www.epocrates.com

Percentage of ADEs avoided with Epocrates

n=321*Statement based on self-reported usage and extrapolated across the Epocrates member base

6

Over 400,000 Hours Likely Saved by Oncologists Annually with Epocrates*

21%> 30 minutes

25%21 – 30

minutes

20%11- 20 minutes

24%5-10 minutes

11%< 5 minutes

Copyright © 2012 Epocrates, Inc. All rights reserved. To learn more about Epocrates, please visit www.epocrates.com

20+ minutessaved daily

n=321*Statement based on self-reported usage and extrapolated across the Epocrates member base

oncologists report saving 20 minutes

or more daily

Nearly

1 in 2

Daily minutes saved

7

54%Frequently or

somewhat frequently learn new information

from DocAlerts

Drug Interaction Checker #1 Feature Attributed to Changing Rx Decisions

72%

Drug interactions

71%

Dosing information

46%

Adverse reactions

43%Contraindications

& cautions

15%Formulary

information

12% Other safety info

92%Make Rx changes

based on Epocrates information

Top features factoring in Rx changes*

Copyright © 2012 Epocrates, Inc. All rights reserved. To learn more about Epocrates, please visit www.epocrates.com

n=321

8

34% Yes, significantly

31% Yes, moderately

25% Yes, somewhat

10% No

Keeping Up with New Clinical Info a Top Challenge for Oncologists

Top 5 greatest challenges for oncologists

46% 44%

38% 36% 34%

Years in

pra

ctice

Has the level of stress grown over the years as practicing

physician?

Copyright © 2012 Epocrates, Inc. All rights reserved. To learn more about Epocrates, please visit www.epocrates.com

n=321

9Copyright © 2012 Epocrates, Inc. All rights reserved. To learn more about Epocrates, please visit www.epocrates.com

Fragmented Care Biggest Challenge Facing Patients

Top 5 greatest challenges for patients

35%

32%

14%

7%6%

93% Diagnosis

91% Tx Options

79% Prognosis

62% Viability estimates

Extre

mely

confident to

confident

Confidence in information disclosed to

patients

n=321

10

Rx information

Lifestyle change tools

Chronic Dx mgmt

Medical adherence

EHR portal

Patient education

>30% of Oncologists Have Recommended an App to Patients

66%

56%

34%

25%

23%

10%

Apps recommended to patients

Copyright © 2012 Epocrates, Inc. All rights reserved. To learn more about Epocrates, please visit www.epocrates.com

n=106

Top apps recommended

Calorie counter/ tracker

Weight loss tracker

Fitness app (e.g. myfitnesspal.com)

Drug information (e.g. Epocrates)

Patient educational apps

11

Physicians Struggle with App Discovery and Recommendations for Patients

App st

ore

An in

tern

et se

arch

eng

ine

A frie

nd o

r col

leag

ue

Confe

renc

e/ tr

ades

how

It's a

n ap

p I u

se

45%41% 40%

23%19%

Where physicians learn about apps to recommend

Over

50% Report not knowing

which apps are ‘good to share’

Copyright © 2012 Epocrates, Inc. All rights reserved. To learn more about Epocrates, please visit www.epocrates.com

n=105

n=216

12Copyright © 2012 Epocrates, Inc. All rights reserved. To learn more about Epocrates, please visit www.epocrates.com

“Phone Calls” Remain Primary Communication Platform for Patients and Peers

Ph

ysi

cian

to P

ati

en

t Ph

ysicia

n to

C

olle

ag

ue

Phone call

84%Phone call

43%

Email

9%Email

32%SMS Message

2%

Patient Portal

3%

Direct Mail Video Chat

2% ~1%

Email SMS Message

Direct MailVideo Chat

7%0%

EHR System Secure Messaging

3%6%

12%

Primary methods of communication with colleagues vs. patients

n=321

13Copyright © 2012 Epocrates, Inc. All rights reserved. To learn more about Epocrates, please visit www.epocrates.com

Perceptions of Cancer are Increasingly Positive

How perceptions of cancer have

changed over the past 5 years:

63%

41%39%

37%

23%

n=321

Chronic Condition:A human health condition or disease that is persistent or otherwise long-lasting in its

effects*

*World Health Organization 2012

14Copyright © 2012 Epocrates, Inc. All rights reserved. To learn more about Epocrates, please visit www.epocrates.com

Oncologist Data and Information Gaps

>55% are concerned about

industry bias in journal articles & clinical trials

Most need information to help improve patient care*

38%

Comparison of

anticancer therapies

19%

Information on enrolling in clinical

trials

17%

Information on research results for existing

therapies

Oncologists highly anticipate development or technology in targeted molecular and genetic therapies

n=321